For a complete description of our services, please visit our web site:
Weill Cornell Gastrointestinal Metabolic Surgery
With the section of Gastrointestinal Metabolic Surgery headed by Francesco Rubino, MD, a pioneer in the field of diabetes surgery, NewYork-Presbyterial Hospital/Weill Cornell Medical Center, has become the first academic medical center in U.S. and worldwide to offer a dedicated and highly specialized approach to surgical treatment of type 2 diabetes. Our program also offers comprehensive treatment approaches to a full range of metabolic diseases and conditions often associated to severe obesity, including hypertension, high cholesterol, non-alcoholic fatty liver disease and obstructive sleep apnea.
